Unresectable Metastatic Melanoma clinical trials

Explore recruiting unresectable metastatic melanoma clinical trials.

Recruiting unresectable metastatic melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Unresectable Metastatic Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Integrated PK/efficacy, safety, and immunogenicity study to demonstrate similarity of JPB898, a proposed biosimilar to nivolumab, to Opdivo® in combination with Yervoy®

Bulgaria, Italy, Hungary, Lithuania, Germany, Spain +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Unresectable Metastatic Melanoma trials by city

Unresectable Metastatic Melanoma in Toronto Unresectable Metastatic Melanoma in Vancouver Unresectable Metastatic Melanoma in Montreal Unresectable Metastatic Melanoma in Calgary Unresectable Metastatic Melanoma in Edmonton Unresectable Metastatic Melanoma in Ottawa Unresectable Metastatic Melanoma in Winnipeg Unresectable Metastatic Melanoma in Quebec City Unresectable Metastatic Melanoma in Hamilton Unresectable Metastatic Melanoma in Kitchener Unresectable Metastatic Melanoma in London Unresectable Metastatic Melanoma in Halifax Unresectable Metastatic Melanoma in New York Unresectable Metastatic Melanoma in Los Angeles Unresectable Metastatic Melanoma in Chicago Unresectable Metastatic Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease